Our Regenerative Medicine Products

We strive to provide our customers with the latest regenerative medicine equipment and supplies to keep them at the cutting edge of one of the most exciting and promising areas of modern medicine.

Our inventory of equipment and supplies includes FDA-registered Class II PRP kits. Our XCELL PRP kits are exceptional in their ability to maximize platelet count through a unique design that reduces total processing time and mitigates the risk of human error. Our system can produce both leukocyte-rich and leukocyte-poor PRP utilizing a variety of centrifuge systems, including some Eppendorf models.

The XCELL PRP Advantage

bullseye-1
FLEXIBILITY

Ability to obtain different volumes, different types of PRP (LR vs LP), and utilize PRP for A2M (Protein Concentrate).

bullseye-1
VOLUME

Draws 50-60 mL producing 6+ mL of highly concentrated PRP

bullseye-1
EASY TO USE

Fast and simple for staff to duplicate

bullseye-1
RESULTS

Provides consistent and reliable results

bullseye-1
PRICE

High quality system that provides superior value for the price ​

bullseye-1
COMPLIANCE

Has a class II 510k approval

+ bps_drucker

APEX Press Releases

APEX Biologix Enters Exclusive U.S. Distribution Agreement with Bioventus LLC for XCELL PRP® System

Clearwater, FL - May 20, 2025 - APEX Biologix, a leading provider of advanced biologic interventions and regenerative medicine solutions, is pleased to announce an exclusive distribution agreement with Bioventus for the XCELL PRP system throughout the United States for...

APEX Biologix Enters Into Know-How License Agreement with Mayo Clinic for Development of Regenerative Medicine Products

SALT LAKE CITY March 09, 2023, APEX Biologix, a leading regenerative medicine device company that specializes in the development of advanced patient therapies, announced today it has entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative...

APEX Biologix Appoints Jim Rogers as New Chief Executive Officer

APEX Biologix, a leader in the regenerative medicine industry, announced today the addition of a new visionary executive to the company. Jim Rogers brings more than 20 years of creation and business development in the medical device industry to the growing team at APEX Biologix.